Report Sections

See All Reports

  • HP:0001511: Intrauterine growth retardation
  • Pneumonia (361) Abnormality of the cardiovascular system (36) Respiratory tract infection (36) Neoplasm (29) Hypoxemia (28) Diabetes mellitus (25) Depressivity (24) Thromboembolism (23) Acute kidney injury (22) Abnormal lung morphology (21) Anosmia (19) Hypertension (18) Abnormality of coagulation (15) Pulmonary embolism (15) Pulmonary fibrosis (15) Stroke (14) Arthritis (14) Interstitial pneumonitis (14) Myocardial infarction (12) Type II diabetes mellitus (12) Deep venous thrombosis (11) Rheumatoid arthritis (10) Leukemia (10) Respiratory distress (10) Low levels of vitamin D (10) Behavioral abnormality (9) Mental deterioration (9) Chronic pain (9) Congestive heart failure (8) Myocarditis (8) Type I diabetes mellitus (8) Sepsis (8) Infertility (7) Abnormality of the liver (7) Lymphopenia (7) Inflammation of the large intestine (7) Pulmonary obstruction (7) Pulmonary insufficiency (7) Immunodeficiency (6) Systemic lupus erythematosus (6) Chronic pulmonary obstruction (6) Abnormality of the gastrointestinal tract (6) Neoplasm of the lung (6) Encephalopathy (5) Obesity (5) Lymphoma (5) Autoimmunity (5) Breast carcinoma (5) Disseminated intravascular coagulation (5) Fatigue (5) Abnormality of the kidney (4) Coronary artery atherosclerosis (4) Cardiac arrest (4) Headache (4) Colon cancer (4) Arrhythmia (4) Carcinoma (4) Hypercoagulability (4) Autistic behavior (3) Seizure (3) Cardiomyopathy (3) Dysphagia (3) Migraine (3) Pulmonary arterial hypertension (3) Asthma (3) Bronchiectasis (3) Neoplasm of the pancreas (3) Psoriasiform dermatitis (3) Attention deficit hyperactivity disorder (3) Cutaneous melanoma (3) Neoplasm of head and neck (3) Pulmonary edema (3) Insomnia (3) Neoplasm of the large intestine (3) Renal insufficiency (2) Hypogeusia (2) Hearing impairment (2) Abnormality of the eye (2) Visual impairment (2) Conjunctivitis (2) Psychosis (2) Autism (2) Dementia (2) Abnormality of the endocrine system (2) Abnormality of the thyroid gland (2) Jaundice (2) Hepatic fibrosis (2) Premature birth (2) Abnormal heart morphology (2) Abnormality of blood and blood-forming tissues (2) Fever (2) Diarrhea (2) Hypothermia (2) Neurodegeneration (2) Abnormal intestine morphology (2) Alopecia of scalp (2) Encephalitis (2) Obstructive sleep apnea (2) Male infertility (2) Stillbirth (2) Paroxysmal atrial fibrillation (2) Lymphoid leukemia (2) Myeloproliferative disorder (2) Chronic lymphatic leukemia (2) Renal cell carcinoma (2) Multiple myeloma (2) Abnormal anterior horn cell morphology (2) Amyotrophic lateral sclerosis (2) Sleep apnea (2) Cystoid macular edema (2) Hemeralopia (2) Arteritis (2) Chronic kidney disease (2) Cervix cancer (2) Cholangitis (2) Cholangiocarcinoma (2) Myositis (2) Neuroendocrine neoplasm (2) Neoplasm of the rectum (2) Mania (2) Nephritis (1) Menorrhagia (1) Conductive hearing impairment (1) Cataract (1) Amblyopia (1) Periodontitis (1) Abnormality of the nervous system (1) Oligospermia (1) Adrenal insufficiency (1) Hyperaldosteronism (1) Abnormality of the skin (1) Lymphedema (1) Cholecystitis (1) Keratoconjunctivitis (1) Intellectual disability (1) Spastic diplegia (1) Hemiparesis (1) Meningitis (1) Cerebral hemorrhage (1) Abnormal joint morphology (1) Hepatic failure (1) Hepatocellular carcinoma (1) Intrauterine growth retardation (1) Hoarse voice (1) Dysphonia (1) Weak voice (1) Sudden cardiac death (1) Cor pulmonale (1) Tachycardia (1) Aortic valve stenosis (1) Bradycardia (1) Torsade de pointes (1) Atrioventricular block (1) Angina pectoris (1) Pancreatitis (1) Premature rupture of membranes (1) Weight loss (1) Thrombocytopenia (1) Autoimmune thrombocytopenia (1) Gastroesophageal reflux (1) Anorexia (1) Esophageal varix (1) Apnea (1) Status epilepticus (1) Subarachnoid hemorrhage (1) Memory impairment (1) Difficulty walking (1) Hyperkinetic movements (1) Alzheimer disease (1) Increased intracranial pressure (1) Colitis (1) Biliary cirrhosis (1) Hypotension (1) Vascular dilatation (1) Atherosclerosis (1) Osteoarthritis (1) Tachypnea (1) Hypoventilation (1) Myelodysplasia (1) Neoplasm of the liver (1) Hypokalemia (1) Hyponatremia (1) Hyperphosphatemia (1) Reduced factor VIII activity (1) Skeletal muscle atrophy (1) Myalgia (1) Muscular dystrophy (1) Neonatal death (1) Increased body weight (1) Neoplasm of the nervous system (1) Malnutrition (1) Thrombophlebitis (1) Ventricular tachycardia (1) Acute myeloid leukemia (1) Dilatation of the cerebral artery (1) Knee osteoarthritis (1) Monoclonal immunoglobulin M proteinemia (1) Intraalveolar phospholipid accumulation (1) Neoplasm of the stomach (1) Neoplasm of the genitourinary tract (1) Neoplasm of the skin (1) Female infertility (1) Benign prostatic hyperplasia (1) Hip osteoarthritis (1) Renal neoplasm (1) Uterine neoplasm (1) Testicular neoplasm (1) Intestinal atresia (1) Tonsillitis (1) Inflammatory abnormality of the skin (1) Placental abruption (1) Postprandial hyperglycemia (1) Endometrial carcinoma (1) Erythroid hypoplasia (1) Asterixis (1) Glioblastoma multiforme (1) B-cell lymphoma (1) Ciliary dyskinesia (1) Morphea (1) Allergy (1) Non-Hodgkin lymphoma (1) Retinal vein occlusion (1) Heart block (1) Dyspareunia (1) Ductal carcinoma in situ (1) Endometriosis (1) Cardiogenic shock (1) Vulvar neoplasm (1) Addictive behavior (1) Femur fracture (1) Neonatal sepsis (1) Glue ear (1) Neoplasm of the central nervous system (1) Abnormality of movement (1) Ulcerative colitis (1) Crohn's disease (1) Endocarditis (1) Toxemia of pregnancy (1) Neoplasm of the larynx (1) Ovarian neoplasm (1) Vaginal neoplasm (1) Cellulitis (1) Bulimia (1) Atelectasis (1) Esophageal neoplasm (1) Lymphocytosis (1) Polymenorrhea (1)

    HP:0001511: Intrauterine growth retardation

    Developed by Shray Alag, The Harker School
    Sections: Correlations, Clinical Trials, and HPO

    Correlations computed by analyzing all clinical trials.

    Navigate: Clinical Trials and HPO


    Correlated Drug Terms (3)


    Name (Synonyms) Correlation
    drug3994 rhDNase I Wiki 1.00
    drug1398 Healthy lifestyle advise Wiki 1.00
    drug1208 Exercise program Wiki 1.00

    Correlated MeSH Terms (5)


    Name (Synonyms) Correlation
    D005317 Fetal Growth Retardation NIH 1.00
    D046110 Hypertension, Pregnancy-Induced NIH 1.00
    D000078064 Gestational Weight Gain NIH 1.00
    Name (Synonyms) Correlation
    D015430 Weight Gain NIH 1.00
    D011248 Pregnancy Complications NIH 0.33

    Correlated HPO Terms (1)


    Name (Synonyms) Correlation
    HP:0004324 Increased body weight HPO 1.00

    Clinical Trials

    Navigate: Correlations   HPO

    There is one clinical trial.


    1 Active Pregnancy, Prevention Against the Effects of COVID-19

    Historically and traditionally, the recommendations related to physical exercise during pregnancy have been based more on moral or cultural issues than on scientific evidence. During some phases of history, pregnancy has meant a period of seclusion for women (not only physical). One of the adverse consequences has been the common recommendation of rest as a general rule for pregnant women. Scientific evidence from recent years has achieved a better understanding of the process of pregnancy and childbirth as well as maternal and fetal responses to exercise. Currently, both from a scientific and clinical/obstetric point of view, there is no doubt about the benefits of an active pregnancy for entire body of pregnant woman, and even her child. In fact, risks of a sedentary lifestyle are applicable to the pregnancy situation, even more with important associated complications during pregnancy and postpartum period. Unfortunately, the impact of COVID-19 has caused an unprecedented global crisis, in this sense the necessary measures taken by the different administrations, especially in terms of confinement causes (from now on) a large number of complications affecting different populations. In summary a complex situation without established prevention strategies exists. The pregnant population is, due to the nature of the gestation and delivery process, one of the population groups with the highest risk of adverse outcomes and associated complications and whose consequences include the mother, fetus, newborn and even children. According to an important body of scientific literature and based on an epigenetic effect, the intrauterine environment can be a determining factor for the future human being to evolve regardless of complications and pathologies (cardiovascular, metabolic, psychic, emotional). This is demonstrated by numerous recent scientific evidences that confirm the unfortunate association between an adverse intrauterine environment (due to various factors) and observable postnatal pathologies in infants. In addition, current publications report the large number and variety of alterations that the COVID-19 situation causes in pregnant women and that includes the entire female organism. This complex situation does not only affect aspects of a physical or physiological nature, but also psychic and emotional factors. In summary, a new state of confinement or similar situations in the near future (impossibility of groupings, distance between people), avoid during the daily life of pregnant women one of the important and recent recommendations made by the international scientific community: a pregnancy physically active. This is especially relevant, due to the dangerous association between complications of a psychological or emotional nature during pregnancy with pre, peri and postnatal disorders (low birth weights, perinatal complications, altered and prolonged deliveries, etc.), which affect not only to the mother and can determine the health of the future human being. According to the scientific literature and based on an epigenetic effect, the intrauterine environment can be a determining aspect in the health of the future human being and the prevention of complications and pathologies (cardiovascular, metabolic, psychic, emotional). This is demonstrated by numerous and recent scientific evidences that confirm the unfortunate association between an adverse intrauterine environment (due to various factors) and different pathologies during and after pregnancy. It is evident the change that COVID-19 and its effects will generate in the lifestyle of the pregnant population and the increased probability of suffering associated pathologies in the next 24-36 months. No preventive actions have yet been planned in Spain and its public hospitals against the impact of COVID-19 on the quality of life of pregnant women. It is urgent to design and perform an adequate strategy of intervention for its possible prevention. From the scientific point of view, the recommendations are clear and concrete, an aerobic exercise program, designed and supervised by professionals from the Sciences of Physical Activity and Sports, is the best option for pregnant women. In this sense, in the last 30 years, physical exercise has proven to have many benefits for pregnant women, without causing risks or adverse effects on maternal-fetal well-being. This is confirmed by an important body of scientific literature on gestational physical exercise and its effects on pregnancy outcomes.

    NCT04563065
    Conditions
    1. Pregnancy Complications
    2. Pregnancy, High Risk
    3. Pregnancy Induced Hypertension
    4. Newborn Morbidity
    5. Fetal Growth Retardation
    6. Fetus Disorder
    7. Weight Gain, Maternal
    8. Maternal-Fetal Relations
    Interventions
    1. Other: Exercise program
    2. Other: Healthy lifestyle advise
    MeSH:Pregnancy Complications Fetal Growth Retardation Hypertension, Pregnancy-Induced Weight Gain Gestational Weight Gain
    HPO:Increased body weight Intrauterine growth retardation

    Primary Outcomes

    Description: analyze the increase during pregnancy

    Measure: Maternal weight gain

    Time: 9 months

    Description: analyze how it varies during pregnancy

    Measure: blood pressure

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: OGTT-O'Sullivan test

    Time: 1 month

    Description: analyze with a questionnaire the value and its interrelationship with physical exercise patterns (different measures in the questionnaire)

    Measure: Urinary Incontinence Questionnaire (ICIQ-SF)

    Time: 9 months

    Description: analyze with a questionnaire the value and its interrelationship with physical exercise patterns (Likert scale 0-3)

    Measure: State-Trait Anxiety Inventory (STAI)

    Time: 9 months

    Description: analyze with a questionnaire the variability during pregnancy (Likert scale 0-3)

    Measure: depression scale (CES-D)

    Time: 9 months

    Description: analyze variability during pregnancy

    Measure: Behavior of Fetal Heart Rate

    Time: 3 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: gestational age

    Time: 9 months

    Description: analyze whether women have had a vaginal, instrumental or cesarean delivery and its interrelationship with physical exercise patterns

    Measure: type of delivery (Vaginal, instrumental or cesarean)

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: duration of labor

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: birthweight

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy

    Measure: child's weight

    Time: 24 months

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy

    Measure: child's height

    Time: 24 months

    Description: analyze the value and its interrelationship with physical exercise patterns during pregnancy (Likert scale 0-3)

    Measure: mental assessment of the child (depression questionnaire adapted to childhood)

    Time: 24 months

    Secondary Outcomes

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Maternal pains during pregnancy (headache, back pain, pelvic pain, paravertebral, scapular, etc.)

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: fetal growth and development

    Time: 9 months

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Delivery tears

    Time: 1 month

    Description: analyze the appearance (descriptive: yes/no) and its interrelationship with physical exercise patterns

    Measure: performing episiotomy during childbirth

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Apgar Score

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: length

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: cranial perimeter

    Time: 1 month

    Description: analyze the value and its interrelationship with physical exercise patterns

    Measure: Landau reflexes test

    Time: 1 month

    Description: analyze the number of admissions and its interrelationship with physical exercise patterns

    Measure: neonatal intensive care unit (NICU)

    Time: 1 month

    Description: analyze how it varies during postpartum period

    Measure: Postpartum recovery of pre-pregnancy weight

    Time: 12 months

    Description: analyze with a questionnaire how it varies during postpartum period (Likert scale 0-3)

    Measure: Edinburgh Postpartum Depression Scale (EPDS)

    Time: 12 months

    Other Outcomes

    Description: analyze the value and its interrelationship with physical exercise patterns (Likert scale)

    Measure: Perception of health status - SF36 health scale

    Time: 24 months

    Description: analyze the diameter and thickness of muscles in the perineal area and its interrelationship with physical exercise patterns

    Measure: Recovery of pelvic floor muscles ultrasound

    Time: 6 months

    Description: analyzewith a questionnaire how it varies during and after pregnancy

    Measure: Maternal habits of physical activity - Pregnancy Physical Activity Questionnaire (PPAQ)

    Time: 12 months

    HPO Nodes


    HP:0001511: Intrauterine growth retardation
    Genes 681
    SMARCB1 RIPPLY2 CLCN7 UBR1 TRAIP MTHFR SIX2 UBR1 NDUFB11 NODAL B3GLCT TOP3A NDUFS4 IARS1 CUL7 ATP6V0A2 NDUFAF4 POLA1 TRAPPC11 DHCR7 WARS2 NDE1 INSR KIF2A PLK4 MCM5 WNT7A TBCE RTL1 ARID2 ASXL1 PHGDH ARID1B FGFR1 CTNND2 PSAT1 ARVCF OSGEP STAG1 FANCM RPL10 HNF4A SHH PRKDC ITPA ZNF335 YY1 HYMAI NELFA RREB1 LMBRD1 RAB3GAP2 KCNJ11 AARS1 GLI1 PDSS2 LETM1 CTBP1 FBN1 P4HB COG4 RFX6 PARN SOX4 PNPT1 GATA6 PAX4 TERT ERCC6 PSAT1 SLC26A2 PIEZO2 RAD51C STN1 DLL1 BUB1B ERCC5 B3GLCT NDUFA6 PRPS1 RTL1 PCNT ABCC8 ELN CDC6 TARS1 NF1 MRPS25 NKX2-6 PIK3R1 TTC7A GATA5 IGF1R RTL1 PHGDH HIRA GP1BB GLI3 BRIP1 ATP6V0A2 VPS13B GFM2 STT3B ZMPSTE24 SEC24C CCNQ ERCC1 FIG4 KLF11 TBC1D20 ARID1B ACD ATP5F1A PDHB RPL11 KIF5C FANCG PET100 NDUFV2 NDUFAF5 GLIS3 ORC4 SOX11 PEX2 SEMA5A AFF2 CKAP2L IGHMBP2 EVC2 SON ATP6V0A2 TRMT10A NIPBL NEUROD1 RBBP8 RTL1 PDGFRB ABCB7 CEP290 SDHAF1 EFEMP2 PDE4D WASHC5 KMT2A PDE4D ESCO2 SLC25A24 SUFU FGFR1 KIF14 CITED2 HOXD13 TTC37 PLAGL1 BLM RNU4ATAC TDGF1 GDF1 RELN PDX1 TINF2 IGF2 FANCD2 ATP6V1E1 SNRPB DLK1 USB1 ZFPM2 SMARCAL1 TMEM70 NUS1 PPP1R15B MEG3 ARL6IP6 NFIX ERCC1 NDUFB10 CNOT1 LIG4 FKTN MADD PDGFB CENPJ FANCL CPLX1 NDUFA11 CTC1 NDUFS3 NCAPG2 SLC35C1 SEMA3E ALDH18A1 ARID1A TAPT1 PSAT1 PCDH12 NBN FLNB SLC35A2 DNMT3A CDC6 BLM ACD ADGRG6 SKIV2L MCM4 FANCI TINF2 IGF1 ND2 WDR4 ORC6 PUF60 ESCO2 PDE4D PLK4 TAF1 FGFRL1 RARB KMT2A FANCF GATA6 ORC4 GATA6 XYLT1 WDR73 APPL1 CDK10 RPS19 FOXRED1 IGF2 KAT6A FLI1 GTPBP3 DLK1 SNRPN CNOT1 UQCRFS1 CDC45 DNAJC21 GCK CTDP1 TCTN3 SCO1 INS MRPS28 QRICH1 ERCC8 NIN UNC80 NDUFB11 COQ9 PLK4 NUP88 PTDSS1 TIMM22 SLC20A2 XRCC4 NDUFAF8 ERCC2 POLR3A ERCC2 SKIV2L SMARCA4 FANCL ASXL1 DHCR7 MMACHC BRAF GCK TMEM216 TUBGCP4 PIGG BRIP1 FANCI NSD2 DPF2 CHRNG CANT1 CEP57 CEP57 ATP7A RAD21 SMARCA2 DOK7 TUFM ORC1 FGF8 RNF113A TBX6 RERE KDM6A FMR1 INS TCTN3 DHDDS TTC7A ZFP57 FANCB CKAP2L CDON TIMMDC1 POLR3A ZFP57 COG5 CDCA7 ERCC1 STRA6 ND1 FOXH1 COG7 PCNT FANCA KLHL7 PTPN11 CDKN1C COG1 PHGDH IARS1 SOX11 OTUD6B HNF1A NDUFAF3 GAS1 GATAD2B NPM1 CENPE RBM10 TBCE KCNJ11 FDFT1 TGDS GPKOW FBLN5 DISP1 PDX1 CEP152 KANSL1 WDR73 MAPK1 CARS1 NIPBL MESP2 PLOD3 SMAD4 SMARCA4 NSUN2 EXOSC9 ZIC2 PCGF2 LIFR BCAP31 DYRK1A PAH RTL1 DONSON MKS1 TSFM FLT4 INSR DYNC2LI1 NDUFB9 DLK1 ADAT3 POLE TBX1 TBCE FAM111A NDUFS8 SMC1A PIEZO2 HDAC6 JMJD1C CREBBP BUB1 ATP6V1A NDUFS6 PALB2 TBX1 ERCC6 COQ7 TOR1A COQ4 TBX1 GINS1 DONSON ABL1 EVC FANCE GCK BCS1L PDX1 TINF2 CORIN MPLKIP PARN ATRIP PPP1R15B CDKN1C SDHB NDUFS1 GATA4 NSD2 MADD NDUFAF5 FANCC BLK TRAIP NDUFA10 PEX5 HMGA2 POLA1 PDHA1 CNOT1 FLT1 COQ2 LMNA EP300 RNU4ATAC BRCA1 CRKL NDUFA6 RNASEH2A GATC NDUFS2 TTC37 ND3 CCDC8 MESD MCTP2 TGIF1 SIN3A TBCE SMARCB1 MBTPS2 BRCA2 ERCC5 SRPX2 SLC18A3 WDR4 RNF113A RAF1 ALG8 NOP10 SMC1A PCNT MUSK MEG3 NOS3 DNAJC19 PYCR1 GATB COG6 DDX11 MUSK GJA5 LRRC32 HYMAI BUB1B STOX1 INSR SMARCC2 SC5D NDUFS7 NDUFA1 LMNA ADGRG1 NUBPL ERCC2 BRPF1 TFAP2A CENPJ CHRNA1 ALX4 NEK9 ORC6 CUL7 RTEL1 INS NDUFB3 FAM20C NUP133 ESCO2 LONP1 HADH ARCN1 SUCLG1 XPR1 TFAM STT3B MAD2L2 STRA6 NUP188 FANCB UNC80 RNU4ATAC GLI3 RTTN RB1 SDHD GLI2 SLX4 SMARCE1 SEC31A IBA57 SMAD4 SLC25A13 CDT1 HMGA2 RECQL4 ATR RAB3GAP1 LEMD3 SF3B4 ABCC8 CDKN1C SRCAP PLAGL1 NDUFAF2 SAMD9 ZMPSTE24 LAGE3 WNT4 NODAL PTCH1 SMARCE1 DYRK1A TFAP2A OBSL1 WRAP53 STAT3 UFD1 HYMAI NDUFV1 ATP7A UBE2T CENPE PLAG1 GBA WARS2 DKC1 CHRNG RTEL1 CDT1 PDE6D TPRKB NKX2-5 FLVCR2 H19 PI4KA HDAC6 VANGL2 ERCC6 RIPK4 TMEM126B SMARCAL1 GTF2H5 DLL3 EIF2AK3 IFIH1 TERT CDKN1C FTO KCNJ11 NDUFB10 RAB18 ALG1 OSGEP GMNN DNAJC19 SETD5 FUT8 TALDO1 UQCC2 RNU4ATAC MYOD1 DYRK1A MEG3 HMGA2 CHD7 NSDHL SMC1A ABCC8 TMEM70 NDUFAF4 ERCC4 LARS2 HHAT SMARCD1 SIX3 RAD51 CTU2 GATA4 TELO2 OTUD6B QRSL1 JAG1 HYLS1 IGF2 CHRND SMC3 SMPD4 SLC25A24 JAM2 NUP107 XRCC2 DKC1 PDX1 IGF1R PKLR CTC1 RAPSN BCS1L NIN BMPER GTF2E2 RERE PIGG LAGE3 H19-ICR LETM1 MTRR TBX4 TP53RK HDAC8 YY1 RFWD3 GFM1 WHCR GFM2 ERCC8 TERC BUB3 HES7 COX6B1 RBM10 DLK1 TRIP13 MLXIPL MEG3 TINF2 ORC1 MYH3 PARN RFWD3 BCR ALDH18A1 DKC1 MEG3 POLE DLK1 TRIM37 PSPH SFXN4 NDUFAF8 ABCC8 GTF2E2 ATR NHP2 COMT NDUFAF1 MYORG TUBGCP6 SEC61A1 NDUFB3 EMG1 BRCA2 DHCR24 ERCC3 RTEL1 HSD11B2 RNU4ATAC LFNG PRKAR1A KCNJ11 CEL SEC24D NALCN IGF1 INS SDHA
    Protein Mutations 1
    G20210A
    SNP 0

    HPO

    Alphabetical listing of all HPO terms. Navigate: Correlations   Clinical Trials


    HPO Nodes


    HP:0001511: Intrauterine growth retardation
    Genes 681
    SMARCB1 RIPPLY2 CLCN7 UBR1 TRAIP MTHFR SIX2 UBR1 NDUFB11 NODAL B3GLCT TOP3A NDUFS4 IARS1 CUL7 ATP6V0A2 NDUFAF4 POLA1 TRAPPC11 DHCR7 WARS2 NDE1 INSR KIF2A PLK4 MCM5 WNT7A TBCE RTL1 ARID2 ASXL1 PHGDH ARID1B FGFR1 CTNND2 PSAT1 ARVCF OSGEP STAG1 FANCM RPL10 HNF4A SHH PRKDC ITPA ZNF335 YY1 HYMAI NELFA RREB1 LMBRD1 RAB3GAP2 KCNJ11 AARS1 GLI1 PDSS2 LETM1 CTBP1 FBN1 P4HB COG4 RFX6 PARN SOX4 PNPT1 GATA6 PAX4 TERT ERCC6 PSAT1 SLC26A2 PIEZO2 RAD51C STN1 DLL1 BUB1B ERCC5 B3GLCT NDUFA6 PRPS1 RTL1 PCNT ABCC8 ELN CDC6 TARS1 NF1 MRPS25 NKX2-6 PIK3R1 TTC7A GATA5 IGF1R RTL1 PHGDH HIRA GP1BB GLI3 BRIP1 ATP6V0A2 VPS13B GFM2 STT3B ZMPSTE24 SEC24C CCNQ ERCC1 FIG4 KLF11 TBC1D20 ARID1B ACD ATP5F1A PDHB RPL11 KIF5C FANCG PET100 NDUFV2 NDUFAF5 GLIS3 ORC4 SOX11 PEX2 SEMA5A AFF2 CKAP2L IGHMBP2 EVC2 SON ATP6V0A2 TRMT10A NIPBL NEUROD1 RBBP8 RTL1 PDGFRB ABCB7 CEP290 SDHAF1 EFEMP2 PDE4D WASHC5 KMT2A PDE4D ESCO2 SLC25A24 SUFU FGFR1 KIF14 CITED2 HOXD13 TTC37 PLAGL1 BLM RNU4ATAC TDGF1 GDF1 RELN PDX1 TINF2 IGF2 FANCD2 ATP6V1E1 SNRPB DLK1 USB1 ZFPM2 SMARCAL1 TMEM70 NUS1 PPP1R15B MEG3 ARL6IP6 NFIX ERCC1 NDUFB10 CNOT1 LIG4 FKTN MADD PDGFB CENPJ FANCL CPLX1 NDUFA11 CTC1 NDUFS3 NCAPG2 SLC35C1 SEMA3E ALDH18A1 ARID1A TAPT1 PSAT1 PCDH12 NBN FLNB SLC35A2 DNMT3A CDC6 BLM ACD ADGRG6 SKIV2L MCM4 FANCI TINF2 IGF1 ND2 WDR4 ORC6 PUF60 ESCO2 PDE4D PLK4 TAF1 FGFRL1 RARB KMT2A FANCF GATA6 ORC4 GATA6 XYLT1 WDR73 APPL1 CDK10 RPS19 FOXRED1 IGF2 KAT6A FLI1 GTPBP3 DLK1 SNRPN CNOT1 UQCRFS1 CDC45 DNAJC21 GCK CTDP1 TCTN3 SCO1 INS MRPS28 QRICH1 ERCC8 NIN UNC80 NDUFB11 COQ9 PLK4 NUP88 PTDSS1 TIMM22 SLC20A2 XRCC4 NDUFAF8 ERCC2 POLR3A ERCC2 SKIV2L SMARCA4 FANCL ASXL1 DHCR7 MMACHC BRAF GCK TMEM216 TUBGCP4 PIGG BRIP1 FANCI NSD2 DPF2 CHRNG CANT1 CEP57 CEP57 ATP7A RAD21 SMARCA2 DOK7 TUFM ORC1 FGF8 RNF113A TBX6 RERE KDM6A FMR1 INS TCTN3 DHDDS TTC7A ZFP57 FANCB CKAP2L CDON TIMMDC1 POLR3A ZFP57 COG5 CDCA7 ERCC1 STRA6 ND1 FOXH1 COG7 PCNT FANCA KLHL7 PTPN11 CDKN1C COG1 PHGDH IARS1 SOX11 OTUD6B HNF1A NDUFAF3 GAS1 GATAD2B NPM1 CENPE RBM10 TBCE KCNJ11 FDFT1 TGDS GPKOW FBLN5 DISP1 PDX1 CEP152 KANSL1 WDR73 MAPK1 CARS1 NIPBL MESP2 PLOD3 SMAD4 SMARCA4 NSUN2 EXOSC9 ZIC2 PCGF2 LIFR BCAP31 DYRK1A PAH RTL1 DONSON MKS1 TSFM FLT4 INSR DYNC2LI1 NDUFB9 DLK1 ADAT3 POLE TBX1 TBCE FAM111A NDUFS8 SMC1A PIEZO2 HDAC6 JMJD1C CREBBP BUB1 ATP6V1A NDUFS6 PALB2 TBX1 ERCC6 COQ7 TOR1A COQ4 TBX1 GINS1 DONSON ABL1 EVC FANCE GCK BCS1L PDX1 TINF2 CORIN MPLKIP PARN ATRIP PPP1R15B CDKN1C SDHB NDUFS1 GATA4 NSD2 MADD NDUFAF5 FANCC BLK TRAIP NDUFA10 PEX5 HMGA2 POLA1 PDHA1 CNOT1 FLT1 COQ2 LMNA EP300 RNU4ATAC BRCA1 CRKL NDUFA6 RNASEH2A GATC NDUFS2 TTC37 ND3 CCDC8 MESD MCTP2 TGIF1 SIN3A TBCE SMARCB1 MBTPS2 BRCA2 ERCC5 SRPX2 SLC18A3 WDR4 RNF113A RAF1 ALG8 NOP10 SMC1A PCNT MUSK MEG3 NOS3 DNAJC19 PYCR1 GATB COG6 DDX11 MUSK GJA5 LRRC32 HYMAI BUB1B STOX1 INSR SMARCC2 SC5D NDUFS7 NDUFA1 LMNA ADGRG1 NUBPL ERCC2 BRPF1 TFAP2A CENPJ CHRNA1 ALX4 NEK9 ORC6 CUL7 RTEL1 INS NDUFB3 FAM20C NUP133 ESCO2 LONP1 HADH ARCN1 SUCLG1 XPR1 TFAM STT3B MAD2L2 STRA6 NUP188 FANCB UNC80 RNU4ATAC GLI3 RTTN RB1 SDHD GLI2 SLX4 SMARCE1 SEC31A IBA57 SMAD4 SLC25A13 CDT1 HMGA2 RECQL4 ATR RAB3GAP1 LEMD3 SF3B4 ABCC8 CDKN1C SRCAP PLAGL1 NDUFAF2 SAMD9 ZMPSTE24 LAGE3 WNT4 NODAL PTCH1 SMARCE1 DYRK1A TFAP2A OBSL1 WRAP53 STAT3 UFD1 HYMAI NDUFV1 ATP7A UBE2T CENPE PLAG1 GBA WARS2 DKC1 CHRNG RTEL1 CDT1 PDE6D TPRKB NKX2-5 FLVCR2 H19 PI4KA HDAC6 VANGL2 ERCC6 RIPK4 TMEM126B SMARCAL1 GTF2H5 DLL3 EIF2AK3 IFIH1 TERT CDKN1C FTO KCNJ11 NDUFB10 RAB18 ALG1 OSGEP GMNN DNAJC19 SETD5 FUT8 TALDO1 UQCC2 RNU4ATAC MYOD1 DYRK1A MEG3 HMGA2 CHD7 NSDHL SMC1A ABCC8 TMEM70 NDUFAF4 ERCC4 LARS2 HHAT SMARCD1 SIX3 RAD51 CTU2 GATA4 TELO2 OTUD6B QRSL1 JAG1 HYLS1 IGF2 CHRND SMC3 SMPD4 SLC25A24 JAM2 NUP107 XRCC2 DKC1 PDX1 IGF1R PKLR CTC1 RAPSN BCS1L NIN BMPER GTF2E2 RERE PIGG LAGE3 H19-ICR LETM1 MTRR TBX4 TP53RK HDAC8 YY1 RFWD3 GFM1 WHCR GFM2 ERCC8 TERC BUB3 HES7 COX6B1 RBM10 DLK1 TRIP13 MLXIPL MEG3 TINF2 ORC1 MYH3 PARN RFWD3 BCR ALDH18A1 DKC1 MEG3 POLE DLK1 TRIM37 PSPH SFXN4 NDUFAF8 ABCC8 GTF2E2 ATR NHP2 COMT NDUFAF1 MYORG TUBGCP6 SEC61A1 NDUFB3 EMG1 BRCA2 DHCR24 ERCC3 RTEL1 HSD11B2 RNU4ATAC LFNG PRKAR1A KCNJ11 CEL SEC24D NALCN IGF1 INS SDHA
    Protein Mutations 1
    G20210A
    SNP 0

    Reports

    Data processed on December 13, 2020.

    An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.

    Drug Reports   MeSH Reports   HPO Reports  

    Interventions

    4,818 reports on interventions/drugs

    MeSH

    706 reports on MeSH terms

    HPO

    306 reports on HPO terms

    All Terms

    Alphabetical index of all Terms

    Google Colab

    Python example via Google Colab Notebook